1. Home
  2. BMBL vs CCCC Comparison

BMBL vs CCCC Comparison

Compare BMBL & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bumble Inc.

BMBL

Bumble Inc.

HOLD

Current Price

$2.87

Market Cap

417.4M

Sector

Technology

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.83

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMBL
CCCC
Founded
2014
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
417.4M
404.7M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
BMBL
CCCC
Price
$2.87
$3.83
Analyst Decision
Hold
Strong Buy
Analyst Count
13
6
Target Price
$4.46
$12.20
AVG Volume (30 Days)
4.0M
4.0M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.45
EPS
0.34
N/A
Revenue
$965,658,000.00
$35,947,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.62
N/A
Revenue Growth
N/A
1.02
52 Week Low
$2.54
$1.69
52 Week High
$8.63
$5.17

Technical Indicators

Market Signals
Indicator
BMBL
CCCC
Relative Strength Index (RSI) 41.84 48.75
Support Level $2.64 $2.38
Resistance Level $3.23 $4.60
Average True Range (ATR) 0.17 0.33
MACD -0.02 -0.08
Stochastic Oscillator 2.42 35.27

Price Performance

Historical Comparison
BMBL
CCCC

About BMBL Bumble Inc.

Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company operates as one operating segment with revenue derived in the form of recurring subscriptions and in-app purchases. The company operates in USA, which derives maximum revenue; and Rest of the World.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: